We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product c... Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). Show more
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today...
Net cash provided by operating and investing activities was $15.8 million in the second quarter and net cash used by operating and investing activities was $57.3 million for the first six months...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today...
Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target Prothena will...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.54 | -2.41718889884 | 22.34 | 22.71 | 20.96 | 529302 | 21.68171991 | CS |
4 | -0.16 | -0.728597449909 | 21.96 | 22.83 | 20.12 | 306616 | 21.44685546 | CS |
12 | 1.25 | 6.08272506083 | 20.55 | 25.42 | 18.99 | 368375 | 21.78333813 | CS |
26 | -4.02 | -15.5693261038 | 25.82 | 26.36 | 18.69 | 461708 | 21.86761916 | CS |
52 | -28.4 | -56.5737051793 | 50.2 | 55.89 | 18.69 | 632526 | 30.36607709 | CS |
156 | -55.1 | -71.6514954486 | 76.9 | 79.749 | 18.69 | 527524 | 42.0516418 | CS |
260 | 13.55 | 164.242424242 | 8.25 | 79.749 | 6.44 | 443125 | 36.96539812 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions